发明名称 Quinazoline derivatives as medicaments
摘要 Quinazoline derivatives have the formula: or the pharmaceutically acceptable salts thereof; wherein each of Z<SUP>5</SUP>, Z<SUP>6</SUP>, Z<SUP>7 </SUP>and Z<SUP>8 </SUP>is N or CH and wherein one or two Z<SUP>5</SUP>, Z<SUP>6</SUP>, Z<SUP>7 </SUP>and Z<SUP>8 </SUP>are N and wherein two adjacent Z positions cannot be N; wherein m and n are each independently 0-3; wherein R<SUP>1 </SUP>is independently OH, SH, NH<SUB>2</SUB>, OR, SR, NHR, halo or R-halide; wherein two adjacent R<SUP>1 </SUP>groups may be joined to form an aliphatic hetero cycle ring of 5-6 members; wherein R<SUP>2 </SUP>is independently R, halo, R-halide, OR-halide, NH<SUB>2</SUB>, CONH<SUB>2 </SUB>or CONHR; wherein R is optionally substituted C<SUB>1</SUB>-C<SUB>12 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>12 </SUB>alkenyl, C<SUB>1</SUB>-C<SUB>12 </SUB>alkynyl, or aryl C<SUB>1</SUB>-C<SUB>12 </SUB>alkyl, containing 0-4 heteroatoms in place of a carbon in the carbon backbone, where the optional substituents are -O, -N, or OH; and wherein R<SUP>3 </SUP>is H or CH<SUB>3</SUB>. Such compounds are useful in pharmaceutical compositions and methods of treating conditions characterized by enhanced TGFbeta activity.
申请公布号 US7232824(B2) 申请公布日期 2007.06.19
申请号 US20040957183 申请日期 2004.09.30
申请人 SCIOS, INC. 发明人 DUGAR SUNDEEP;CHAKRAVARTY SARVAJIT;MURPHY ALISON;MCENROE GLENN;CONTE AURELIA;PERUMATTAM JOHN J.
分类号 C07D239/94;A61K;A61K31/4965;A61K31/517;A61K31/519;C07D471/04;C07D475/10;C07D487/04 主分类号 C07D239/94
代理机构 代理人
主权项
地址